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Abstract
Dietary factors regulateimmunological function, but the underlying mechanismsremain elusive. Here we show thatvitamin B9 is
a survival factor for regulatory T (Treg) cells expressing high levels of vitamin B9 receptor (folate receptor 4). In vitamin B9-
reduced condition in vitro,T r e gc e l l sc o u l db ed i f f e r e n t i a t e df r o mn a ı ¨ve T cells but failed to survive. The impaired survival of Treg
cellswasassociatedwithdecreasedexpressionofanti-apoptoticBcl2andindependentofIL-2.In vivo depletionofdietaryvitamin
B9 resulted in the reduction of Treg cells in the small intestine, a site for the absorption of dietary vitamin B9. These findings
providea new link between diet and the immune system,whichcould maintain the immunological homeostasis in the intestine.
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Introduction
To achieve immunosurveillance and immunological homeosta-
sis at the interface between the interior and exterior of the
gastrointestinal tract, the intestinal immune system tightly balances
states of immune activation and quiescence [1]. Thus, gastroin-
testinal tissues contain numerous kinds of T cells, such as Th1,
Th2, Th17, forkhead box P3 (Foxp3)
+ regulatory T (Treg) cells,
IL-10–producing Foxp3
2 T regulatory type 1 cells, and T cells
expressing cd T cell receptor, which together create the
appropriate immunological environment.
Th17 and Treg cells are observed most frequently in the
intestine, and their preferential differentiation is achieved by a
unique cytokine environment created by transforming growth
factor b (TGF-b), IL-6, and IL-23 [2]. In addition to these host-
derived factors, the development and function of the immune
system are influenced by crosstalk with environmental factors [3].
For example, stimulation by segmented filamentous bacteria
results in the preferential induction of Th17 cells, whereas colonic
Treg cells are induced by crosstalk between epithelial cells and
Clostridium clusters IV and XIVa [4,5,6].
Nutritional molecules are also considered to be essential
environmental factors for the development, maintenance, and
regulation of gut immune responses. Thus, deficient or inappro-
priate nutritional intake increases the risk of infectious, allergic,
and inflammatory diseases [7,8]. Among various dietary factors,
vitamins are important participants in the regulation of immune
responses. For example, vitamin A is converted into retinoic acid
(RA) by gut-associated dendritic cells; RA induces the expression
of gut-homing molecules (e.g., a4b7 integrin and CCR9) on
activated T and B cells [9,10] and promotes the preferential
differentiation of Treg cells and the simultaneous inhibition of
Th17 cells [11,12,13,14]. Vitamin B6 is required for the metabolic
pathway of sphingosine 1-phosphate, a lipid mediator that
regulates cell trafficking [15]; disruption of vitamin B6 function
results in aberrant T-cell differentiation and cell trafficking in both
systemic and intestinal compartments [16,17,18].
Vitamin B9 (also known as folate and folic acid) is a water-
soluble vitamin derived from both diet and commensal bacteria
[19]. Vitamin B9 is essential for the synthesis, replication, and
repair of nucleotides for DNA and RNA and is thus required for
cell proliferation and survival [20]. Methotrexate (MTX) acts as a
vitamin B9 antagonist and blocks vitamin B9–mediated nucleotide
synthesis, making MTX useful as an anti-tumor [21] and anti-
rheumatoid arthritis agent [22]. Vitamin B9 deficiency also
reduces the proliferative responses of lymphocytes and natural
killer cell activity [23,24]. Additionally, the vitamin B9 receptor
folate receptor 4 (FR4) is both a marker of Treg cells and is
immunologically functional [25]; however, how it functions in the
intestinal immune system is largely unknown. In this study, we
examined the role of vitamin B9 in the regulation of Treg cell in
vitro and in vivo.
Materials and Methods
Mice and experimental treatment
Female Balb/c mice (7–9 wk of age) were purchased from
Japan Clea (Tokyo, Japan). Vitamin B9–deficient and control
PLoS ONE | www.plosone.org 1 February 2012 | Volume 7 | Issue 2 | e32094diets composed of chemically defined materials (Oriental Yeast,
Tokyo, Japan) were used within 3 months. All animals were
maintained in the experimental animal facility at the University
of Tokyo, and the experiments were approved by the Animal
Care and Use Committee of the University of Tokyo and
conducted in accordance with their guidelines (Approval #20–
28).
Lymphocyte isolation
Lymphocytes were isolated from the lamina propria (LP), as
previously described [18,26]. Briefly, lymphocytes were isolat-
ed from dissected PPs by enzymatic dissociation using
collagenase (Wako, Osaka, Japan). To isolate lymphocytes
from the LP of jejunum/duodenum, PPs were removed and the
remaining intestinal tissue was cut into 2-cm pieces and stirred
in RPMI 1640 medium containing 1 mM EDTA and 2% fetal
calf serum (FCS). The tissue pieces were then stirred in 0.5 (for
small intestine) or 1.0 (for large intestine) mg/mL collagenase,
a n dt h ed i s s o c i a t e dc e l l sw e r esubjected to centrifugation
through a discontinuous Percoll gradient. Lymphocytes were
isolated at the interface between the 40% and 75% Percoll
layers.
Flow cytometry and cell sorting
Flow cytometry and cell sorting were performed as previously
described [18,26]. Cells were pre-incubated with anti-CD16/32
antibodies and then stained with fluorescent antibodies specific for
CD4, ICOS, and GITR (BD Biosciences, San Jose, CA) and FR4
(Biolegend). A Via-probe solution (BD Biosciences) was used to
discriminate between dead and living cells. Intracellular staining of
Foxp3 (eBioscience, San Diego, CA), phosphorylated STAT5,
Ki67 and Bcl2 (BD Biosciences) was performed in accordance with
the manufacturers’ instructions. Flow cytometry and cell sorting
were carried out using the FACSCantoII and FACSAria systems
(BD Biosciences), respectively.
Vitamin B9 measurement
To measure vitamin B9 concentrations, intestinal washes were
collected by washing 12 cm of jejunum/duodenum or whole colon
with 1 mL of PBS. The vitamin B9 concentration in intestinal
washes and serum was measured with a RIDASCREEN enzyme
immunoassay kit (R-Biopharm AG, Darmstadt, Germany) in
accordance with the manufacturer’s instructions. To measure the
amounts of intracellular vitamin B9, 5610
6 purified cells were
washed twice with PBS, and a cell lysate was obtained by
homogenizing cells in PBS containing 0.01% NP-40. After cell
debris was removed by centrifugation, vitamin B9 amounts in the
supernatant were measured with a RIDASCREEN enzyme
immunoassay kit.
In vitro culture
For the induction of Treg cells from naı ¨ve T cells,
CD62L
hiCD4
+ naı ¨ve T cells (10
5 cells/well) were cultured for 4
days with 5 mg/mL of immobilized anti-CD3 antibody and 1 mg/
mL of an anti-CD28 antibody (BD Biosciences) plus 2 ng/mL of
human TGF-b (PeproTech, Rocky Hill, NJ) in vitamin B9–null or
normal RPMI 1640 medium containing 10% FCS. To examine
the maintenance of differentiated Treg cells, purified CD25
+CD4
+
T cells (10
5 cells/well) were cultured for 4 days with 5 mg/mL of
immobilized anti-CD3 antibody with or without 1000 units/mL of
IL-2 (Peprotech) in vitamin B9–null or normal RPMI 1640
medium containing 10% FCS in the presence or absence of
100 nM MTX.
Statistics
Results were compared with the Student’s t-test by using
GraphPad Prism (GraphPad Software, San Diego, CA). Statistical
significance was established at P,0.05.
Results
Vitamin B9 is required for the survival of Foxp3
+ Treg
cells
Foxp3
+ Treg cells express high levels of FR4, which is essential
for their maintenance [25]. We therefore examined whether
vitamin B9 is required for the differentiation of Treg cells from
naı ¨ve T cells, the survival of differentiated Treg cells, or both. To
address this, we initially performed an in vitro T-cell differentiation
assay. Purified naı ¨ve CD4
+ T cells were stimulated with anti-CD3
and anti-CD28 antibodies plus TGF-b in complete or vitamin B9–
reduced medium. Although a small amount of vitamin B9 is
supplied from fetal calf serum (FCS) even in vitamin B9–null
medium (0.2 ppb, compared with 25 ppb in normal medium), the
total cell number was decreased in the condition with reduced
vitamin B9 compared to the control; however, Foxp3
+ Treg cells
were generated at a normal frequency (Fig. 1A).
To investigate the effects of vitamin B9 on differentiated Treg
cells, we cultured CD25
+ Treg cells with anti-CD3 antibodies. The
total cell number was significantly lower in the vitamin B9–
reduced condition than in the control condition (Fig. 1B). The
reduction in cell number occurred predominantly among the
Foxp3
+CD4
+ Treg cells (Fig. 1B). The reduction of FR4
hiFoxp3
+
T cells was dependent on the dose of vitamin B9 (Fig. 1C).
We then measured the expression of Ki67 and anti-apoptotic
Bcl-2 to investigate whether decreased number of Foxp3
+CD4
+
Treg cells in vitamin B9–reduced medium was due to the defects
of cell proliferation, survival, or both. We found that both Ki67
and Bcl2 were decreased in Foxp3
+CD4
+ Treg cells cultured in
vitamin B9 vitamin B9–reduced medium, but magnitude of Bcl2
reduction was higher than Ki67 reduction (Fig. 2A and B). These
findings suggest that vitamin B9 is preferentially but not
exclusively required for the survival of Treg cells in vitro.
Vitamin B9 carrier-mediated pathway is not specifically
involved in the survival of Treg cells
Because vitamin B9 is highly hydrophilic, mammalian cells must
actively mediate the entry of vitamin B9 into cells by carrier- or
receptor-mediated pathways [27]. Carriers include the proton-
coupled folate transporter and the reduced folate carrier [27]. To
examine whether a carrier-mediated pathway is involved in
maintaining Treg cells, we employed MTX, an antagonist of
vitamin B9 that is transported mainly via the reduced folate carrier
and rarely via folate receptors [28,29]. MTX treatment reduced
the numbers of both Treg and non-Treg cells (Fig. 3), suggesting
that the carrier-mediated pathway does not specifically maintain
Treg cells.
Vitamin B9 is an IL-2–independent survival factor for Treg
cells
Treg cells could vigorously proliferate in some circumstances
(e.g., antigen-specific activation through their highly sensitive
TCR signaling [30] and IL-2-mediated activation [31]), which led
to a hypothesis that Treg cells simply require large amounts of
vitamin B9 as a source of nucleotides, and thus Treg cells might
express FR4 as an additional means of acquiring vitamin B9. If so,
FR4
hi Treg cells should contain a larger amount of vitamin B9 in
the intracellular compartments; however, the amount of intracel-
Vitamin B9 in the Maintenance of Treg Cells
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hi Treg and FR4
low/2
non-Treg cells (Fig. 4A). Thus, FR4 might have an additional
specific function for the survival of Treg cells.
IL-2 stimulation enhance the survival of Treg cells [31,32,33].
The FR4-mediated vitamin B9 signal might undergo crosstalk with
IL-2-mediated signaling to maintain the survival of FR4
hiFoxp3
+
Treg cells. To test this, Treg cells were cultured with an anti-CD3
antibody together with IL-2. Although the absolute cell numbers
were low in the reduced vitamin B9 condition, the magnitude of the
IL-2-mediated enhancement of Treg cell growth was similar in the
control and vitaminB9-reducedconditions (Fig. 4B). Consistent with
this finding, comparable expression of phosphorylated STAT5 was
noted in the control and vitamin B9-reduced conditions (Fig. 4C).
Dietary vitamin B9 maintains Foxp3
+ Treg cells in the
small intestine
To examine whether vitamin B9 affects Treg cells in vivo,w e
maintained mice on a vitamin B9–depleted diet for 8 wk. Mice
maintained with vitamin B9(2) diet showed less vitamin B9 in the
small-intestinal wash than controls (Fig. 5A). In contrast, the
amounts of vitamin B9 in the large-intestinal wash and serum were
not different in those mice (Fig. 5A), presumably due to vitamin B9
production from commensal bacteria [19].
We then focused on Treg cells in the mice maintained with
vitamin B9(2) diet. Consistent with our in vitro data, the small
intestines of mice maintained with vitamin B9(2) diet had fewer
Foxp3
+ Treg cells than those of control mice (p=0.018), and there
was no statistical difference (p=0.3022) in the number of
Foxp3
2CD4
+ non-Treg cells (Fig. 5B). The number of Treg and
Figure 2. Vitamin B9 is essential for the survival of Treg cells.
CD25
+CD4
+ T cells were cultured with anti-CD3 antibodies in Vit B9(+)
or Vit B9(2) medium. The expression of Ki67 (A) and Bcl2 (B) in
Foxp3
+CD4
+ T cells were determined by flow cytometry (top panels)
and graphs show the means fluorescent intensity (MFI; bottom panels).
Data are means 6 SD (n=3). Data are representative of 4 independent
experiments.
doi:10.1371/journal.pone.0032094.g002
Figure 3. Vitamin B9 carrier-mediated pathway is not specific
pathway in the maintenance of T cell survival. CD25
+ CD4
+ T cells
were cultured with an anti-CD3 antibody in complete medium
containing 100 nM methotrexate (MTX), and the frequency and
absolute cell numbers of Foxp3
+ and Foxp3
2 CD4
+ T cells were
determined. Data are means 6 SEM (n=4). Data are representative of
two independent experiments.
doi:10.1371/journal.pone.0032094.g003
Figure 1. Requirement of vitamin B9 for the maintenance of Treg cells. (A) Purified naı ¨ve CD4
+ T cells were stimulated with anti-CD3 and
anti-CD28 antibodies plus TGF-b in the presence of normal [Vit B9(+)] or reduced [Vit B9(2)] amounts of vitamin B9. After 4 days, total cell numbers
were calculated, and the differentiation into Foxp3
+ Treg cells was examined by flow cytometry. Data are means 6 SEM (n=4). (B) CD25
+CD4
+ T cells
were cultured with anti-CD3 antibodies in Cont or B9(2) medium. The frequencies of Foxp3
+ and Foxp3
2CD4
+ T cells (B) were determined by flow
cytometry. Cell numbers were calculated using the total cell number and flow cytometric data. Data are means 6 SEM (n=6). (C) Experiments similar
to that shown in (B) were performed with different concentrations of vitamin B9. The relative cell number of Foxp3
+ Treg cells is expressed as a ratio
to the cell number in control medium. The values and means are indicated with dots and lines, respectively. Similar results were obtained from 2
independent experiments.
doi:10.1371/journal.pone.0032094.g001
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purified CD4
+FR4
hi Treg or CD4
+FR4
low/2 non-Treg cells. Data are means 6 SEM (n=4). (B, C) Experiments similar to those shown in Fig. 1B were
performed in the presence of anti-CD3 antibody stimulation with or without IL-2 stimulation. Cell number of Foxp3
+CD4
+ T cells (B) and the
expression of phosphorylated STAT5 (pSTAT5) in Foxp3
+CD4
+ T cells (C) were determined. Data in (B) are means 6 SEM (n=6). Similar results were
obtained from 3 separate experiments.
doi:10.1371/journal.pone.0032094.g004
Figure 5. Depletion of dietary vitamin B9 selectively reduces Treg cells in the small intestine. Mice were maintained on a control [Vit
B9(+)] or vitamin B9-depleted [Vit B9(2)] diet for 8 wk. (A) Vitamin B9 concentrations were measured in intestinal washes of the small intestine (SI),
large intestine (LI), and serum. The data are mean 6 SEM (n=6). (B, C) The frequency and cell numbers of Foxp3
+ and Foxp3
2 CD4
+ T cells in the
small intestine (B), colon, and spleen (C) were calculated using the total cell number and flow cytometric data (mean 6 SEM, n=6). (D) Flow
cytometric analysis was performed to determine the expression levels of Foxp3, CTLA4, and GITR on the surface of FR4
low/2 (thin line) and FR4
hi (thick
line) CD4
+ T cells in the LP. Similar results were obtained from 3 separate experiments.
doi:10.1371/journal.pone.0032094.g005
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spleen of mice maintained with vitamin B9(2) diet (Fig. 5C),
which could be explained by the similar concentration of vitamin
B9 in the large-intestinal washes and sera of both groups of mice.
We also found that Foxp3 and the inhibitory molecules CTLA4
and GITR, which are specifically expressed on Treg cells, were
comparable between those mice (Fig. 5D).
Discussion
We have shown that vitamin B9 is crucial for the maintenance
of Treg cells. Intriguingly, vitamin B9 was required for the survival
of differentiated Treg cells, but was not necessary for the
differentiation of naı ¨ve T cells into Treg cells. This selective effect
of vitamin B9 on Treg cells is opposite to the effect of RA, a
vitamin A metabolite, which enhances the differentiation of naı ¨ve
T cells into Treg cells [11,12,13,14]. RA also induces the
expression of gut-homing molecules (e.g., a4b7 integrin and
CCR9) on B and T cells activated by gut dendritic cells [9,10].
Because CCR9 was expressed normally on Treg cells in the LP of
mice maintained with vitamin B9(2) diet (data not shown), the
deficiency of dietary vitamin B9 did not affect the RA-mediated
expression of gut-homing molecules and, predictably, the
induction of Treg cells in the small intestine.
Treatment with the vitamin B9 antagonist MTX affected
survival of both Treg cells and non-Treg cells, suggesting that the
carrier-mediated pathway maintains sufficient amounts of intra-
cellular vitamin B9 for cell survival regardless of the T-cell subset.
The indiscriminate effects of MTX could be explained by the
ubiquitous expression of the folate carrier [29,34]. As the
mechanism of FR4-mediated Treg-cell maintenance, we consid-
ered initially that the proliferative activity of Treg cells could
require large amounts of vitamin B9 as a source of nucleotides for
DNA and RNA. However, the amounts of intracellular vitamin B9
were identical between Treg and non-Treg cells, implying that
FR4 specifically recognizes extracellular vitamin B9 for the
maintenance of Treg cell survival, consistent with a report that
FR4 expressed on Treg cells contributes to their immune function
and survival [25]. Additionally, the specific biological functions of
vitamin B9 receptors (FR1, FR2, and FR4) have been predicted on
the basis of their ,70% amino acid sequence identity, but the
expression of each receptor is rigidly restricted, with narrow tissue
and cell specificity [35,36]. Because FR1, FR2, and FR4 are
glycosyl phosphatidylinositol–anchored proteins [37], adapter
molecules may assist FR4 in the maintenance of Treg cell survival.
We found that vitamin B9/FR4 was not associated with IL-2–
mediated signaling in Treg cells. We will continue to study how
FR4-mediated vitamin B9 regulates the survival of Treg cells.
Mammals must obtain vitamin B9 from the diet or from
commensal bacteria. The absorption of vitamin B9 from the diet
occurs mainly in the small intestine, whereas the uptake of
microbial vitamin B9 predominantly occurs in the colon [38]. This
explains why depletion of dietary vitamin B9 specifically decreased
Treg cells in the small intestine, but not in the colon. It has been
proposed that bacterial vitamin B9 absorbed in the colon affects
the vitamin B9 status of the host [39,40], which may explain the
lack of changes in vitamin B9 in the serum and splenic Treg cells
in mice maintained with vitamin B9(2) diet. Bifidobacterium, one of
the most important genera of commensal bacteria to be used as a
probiotic, is well-studied as a vitamin B9 producer [41], and
colonic Treg cells are specifically induced by immunological
crosstalk with commensal bacteria, especially Clostridium clusters
IV and XIVa [5]. Although whether Clostridium clusters IV and
XIVa produce vitamin B9 remains unclear, our current findings
suggest that vitamin B9 is an essential survival factor for Treg cells
and, in vivo situation, diet vitamin B9 establishes an immunolog-
ical network in the maintenance of Treg cells specifically in the
small intestine.
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